CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
This is a multi-center, double-blind, placebo-controlled, randomized trial of dupilumab adjunctive therapy for prevention of asthma exacerba....
Phase 2
Chicago, Illinois, United States and 6 other locations
This study will assess the efficacy and safety of dexpramipexole as an adjunctive oral therapy in participants with inadequately controlled asthma...
Phase 3
Berwyn, Illinois, United States and 125 other locations
The purpose of this study is to evaluate dexpramipexole as an add-on oral therapy in participants with inadequately controlled eosinophilic asthma...
Phase 3
Chicago, Illinois, United States and 196 other locations
Phase 2 study to evaluate the safety, tolerability, PK, immunogenicity, and pharmacodynamics of solriktug with adult participants with asthma...
Phase 2
Winfield, Illinois, United States and 22 other locations
To asses effectiveness and safety of tezepelumab in adult and adolescent participants with severe asthma including several under-studied pop...
Phase 4
Chicago, Illinois, United States and 34 other locations
The purpose of this study is to assess the PD equivalence of the approved asthma combination therapy, BDA, delivered using the proposed repl....
Phase 3
River Forest, Illinois, United States and 136 other locations
The study is being conducted to evaluate the effect of 3 dosing regimens of povorcitinib on pulmonary function
Phase 2
Glenview, Illinois, United States and 84 other locations
BID using a dry-powder inhaler at one dose level over a 12-week Treatment period in adult participants with uncontrolled moderate-to-severe asthma...
Phase 2
Hammond, Indiana, United States and 158 other locations
This study is researching a drug called dupilumab. The study is focused on patients who have uncontrolled asthma. Asthma is a condi...
Phase 4
Chicago, Illinois, United States and 28 other locations
treatment in children 2 to \<6 years of age with uncontrolled asthma and/or recurrent severe asthmatic wheeze. The study will be conducted i...
Phase 3
Chicago, Illinois, United States and 57 other locations
Clinical trials
Research sites
Resources
Legal